Production of a HER2 binding nanobody for the assembly of targeted novel dendrimer therapeutics for breast and gastric cancer

Read full text
Authors: Therapeutic Innovation Australia
Cited by: 0

Fields of Study & Subjects

Dendrimers and Hyperbranched Polymers Monoclonal and Polyclonal Antibodies Research HER2/EGFR in Cancer Research

Publication details

Journal / source
Therapeutic Innovation Australia
Publication date
17 February 2026
Language
EN